Bayer, the maker of Roundup weed killer, has agreed to increase the compensation the company will pay to resolve future non-Hodgkin’s lymphoma claims to $2 billion, after announcing an initial proposal last year that would have set aside $1.25 billion for future cases alleging that Roundup causes cancer. If you or someone you love has …
Bayer Increases Payout for Future Roundup Cancer Claims to $2 Billion Read More »
Penumbra is recalling more than 30,000 units of its JET 7 Catheters with Xtra Flex Technology (JET 7 Xtra Flex) due to concerns about an increased risk of serious injury and death in ischemic stroke patients who undergo blood clot removal procedures in which the aspiration catheters are used. The catheter recall was announced after …
More and more women are coming forward with stories about Paragard birth control devices that broke apart after implantation or during removal and left IUD fragments inside their bodies. The Paragard IUD has been on the market in the United States for more than 30 years, but the device has made headlines recently because of …
IUD Fracture an Increasing Problem with Paragard Read More »
Despite increasing concerns about the potential health risks of vaping and new restrictions on the sale of e-cigarette products, one in five high school students and one in 20 middle school students in the United States still vape, says a new study from the U.S. Centers for Disease Control and Prevention (CDC). The agency’s Morbidity …
One in Five High School Students Still Use E-Cigarettes, CDC Study Reveals Read More »
Bayer, the maker of the female sterilization device Essure, announced last week that it would pay about $1.6 billion to resolve approximately 90% of the nearly 39,000 U.S. Essure claims involving women who allegedly suffered injuries caused by the controversial birth control device. The German medical device maker announced the Essure settlement in a statement …
Bayer Agrees to Settle Essure Injury Lawsuits for $1.6 Billion Read More »
Bayer, the maker of the highly controversial Roundup weed killer, has announced a plan to settle most of the Roundup cancer lawsuits currently pending against the company, as well as possible future claims, for more than $10 billion. The announcement came on June 24, 2020, after years of litigation from farmers, agricultural workers, groundskeepers, homeowners …
Bayer Will Pay $10 Billion to Resolve Tens of Thousands of Roundup Cancer Claims Read More »
Learn More About Elmiron Learn more about Elmiron Vision Loss risks and lawsuits by clicking on the link here: Elmiron Vision Loss Dismiss this alert. Significant new safety warnings have been added to the label for Elmiron, a medication commonly prescribed to treat pain and discomfort associated with a bladder condition called interstitial cystitis (IC). …
Major Elmiron Warning Label Update Highlights Risk of Retinal Damage Side Effects Read More »
The surviving family member of a Pennsylvania man who died from pancreatic cancer last year has filed a wrongful death lawsuit against the makers of Zantac, alleging that years of exposure to carcinogenic chemicals in the recalled heartburn drug caused her loved one’s death. The Zantac wrongful death lawsuit was filed late last month in …
Family Sues Zantac Makers Over Fatal Case of Pancreatic Cancer Read More »
Faced with nearly 20,000 lawsuits involving talcum powder cancer claims, Johnson & Johnson announced this week that it will no longer sell talc-based Baby Powder, a product that has been a hallmark of the company for more than a century. Since 1894, Johnson & Johnson has marketed its talcum powder products as safe, pure and …
J&J Discontinues Talc-Based Baby Powder Amid Nearly 20,000 Cancer Claims Read More »
The federal judge overseeing the Zantac multidistrict litigation (MDL) has chosen more than two dozen plaintiffs’ attorneys to serve in leadership positions in the growing litigation over the recalled heartburn drug Zantac and its potential to cause cancer in users. After interviewing 62 attorneys involved in the Zantac MDL, U.S. District Judge Robin L. Rosenberg …
